• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实践公告第 186 号:长效可逆避孕:植入物和宫内节育器。

Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.

出版信息

Obstet Gynecol. 2017 Nov;130(5):e251-e269. doi: 10.1097/AOG.0000000000002400.

DOI:10.1097/AOG.0000000000002400
PMID:29064972
Abstract

Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use. In addition, after the device is removed, the return of fertility is rapid (1, 2). The purpose of this Practice Bulletin is to provide information for appropriate patient selection and evidence-based recommendations for LARC initiation and management. The management of clinical challenges associated with LARC use is beyond the scope of this document and is addressed in Committee Opinion No. 672, Clinical Challenges of Long-Acting Reversible Contraceptive Methods (3).

摘要

宫内节育器和避孕植入物,也称为长效可逆避孕方法(LARC),是最有效的可逆避孕方法。与其他可逆避孕方法相比,LARC 的主要优势在于,长期有效使用时无需患者持续投入精力。此外,取出装置后,生育力迅速恢复(1,2)。本实践公告的目的是为 LARC 的启动和管理提供适当的患者选择和基于证据的建议信息。与 LARC 使用相关的临床挑战的管理不在本文档的范围内,详见委员会意见 No.672《长效可逆避孕方法的临床挑战》(3)。

相似文献

1
Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.实践公告第 186 号:长效可逆避孕:植入物和宫内节育器。
Obstet Gynecol. 2017 Nov;130(5):e251-e269. doi: 10.1097/AOG.0000000000002400.
2
Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.实践公告第 186 号摘要:长效可逆避孕:植入物和宫内节育器。
Obstet Gynecol. 2017 Nov;130(5):1173-1175. doi: 10.1097/AOG.0000000000002394.
3
Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant.长效可逆避孕方法:宫内节育器和皮下埋植避孕剂。
Obstet Gynecol. 2011 Mar;117(3):705-719. doi: 10.1097/AOG.0b013e31820ce2f0.
4
Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.采用短效避孕方法的女性对长效可逆避孕方法的接受度及意外妊娠情况:一项随机患者偏好试验
Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20.
5
Peer counselling for the promotion of long-acting, reversible contraception among teens: a randomised, controlled trial.同伴咨询促进青少年长效可逆避孕:一项随机对照试验。
Eur J Contracept Reprod Health Care. 2016 Oct;21(5):380-7. doi: 10.1080/13625187.2016.1214698. Epub 2016 Aug 8.
6
ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.美国妇产科医师学会委员会意见 No.735:青少年和长效可逆避孕:植入物和宫内节育器。
Obstet Gynecol. 2018 May;131(5):e130-e139. doi: 10.1097/AOG.0000000000002632.
7
Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.美国军事医疗系统中长效可逆避孕方法的启动与持续使用情况
Am J Obstet Gynecol. 2016 Sep;215(3):328.e1-9. doi: 10.1016/j.ajog.2016.03.027. Epub 2016 Mar 19.
8
Availability of long-acting reversible contraceptives in Los Angeles County clinics through a Medicaid state plan amendment program.通过医疗补助州计划修正案项目在洛杉矶县诊所提供长效可逆避孕措施。
Contraception. 2018 Dec;98(6):471-475. doi: 10.1016/j.contraception.2018.07.138. Epub 2018 Aug 1.
9
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.英国长效可逆避孕方法的成本效益:基于为英国国家卫生与临床优化研究所(NICE)临床实践指南开发的决策分析模型的分析
Hum Reprod. 2008 Jun;23(6):1338-45. doi: 10.1093/humrep/den091. Epub 2008 Mar 26.
10
Postpartum contraception: initiation and effectiveness in a large universal healthcare system.产后避孕:大型全民医疗保健系统中的起始情况与有效性
Am J Obstet Gynecol. 2017 Jul;217(1):55.e1-55.e9. doi: 10.1016/j.ajog.2017.02.036. Epub 2017 Feb 28.

引用本文的文献

1
Contraceptive access and use of long-acting reversible contraceptives during the COVID-19 pandemic and beyond.在新冠疫情期间及之后的避孕措施获取情况以及长效可逆避孕方法的使用情况。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251351740. doi: 10.1177/17455057251351740. Epub 2025 Jul 9.
2
Long-acting reversible contraception and unintended pregnancy among U.S. active duty service members, 2017-2018.2017 - 2018年美国现役军人中的长效可逆避孕与意外怀孕情况
MSMR. 2025 May 1;32(5):30-33.
3
Retention of a Copper T380A Intrauterine Device for 29 Years in a 64-Year-Old Female With Postmenopausal Bleeding.
一名64岁绝经后出血女性体内的铜T380A宫内节育器留存29年
Cureus. 2025 Apr 17;17(4):e82444. doi: 10.7759/cureus.82444. eCollection 2025 Apr.
4
The Experiences of Women Who Have Used Intrauterine Devices for a Long Time.长期使用宫内节育器的女性的经历
Nurs Health Sci. 2025 Jun;27(2):e70116. doi: 10.1111/nhs.70116.
5
Understanding Discontinuation Rates and Acceptance of the Low-Dose Levonorgestrel Intrauterine System in Spain: A Comprehensive Analysis of Bleeding Patterns and Influencing Factors.了解西班牙低剂量左炔诺孕酮宫内节育系统的停用率和接受情况:对出血模式及影响因素的综合分析。
Womens Health Rep (New Rochelle). 2025 Mar 5;6(1):209-220. doi: 10.1089/whr.2024.0113. eCollection 2025.
6
Hysteroscopic Removal of an Intrauterine Contraceptive Device Obstructed by Polyps: A Case Study.宫腔镜下取出被息肉阻塞的宫内节育器:一例病例报告
Cureus. 2025 Jan 26;17(1):e77990. doi: 10.7759/cureus.77990. eCollection 2025 Jan.
7
Retained versus removed copper intrauterine device during pregnancy: An updated systematic review and meta-analysis.孕期宫内节育器铜保留与取出情况:一项更新的系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2025 May;104(5):804-814. doi: 10.1111/aogs.15061. Epub 2025 Jan 27.
8
Review of Publicly Available State Reimbursement Policies for Removal and Reinsertion of Long-Acting Reversible Contraception.长效可逆避孕措施取出与重新植入的公开可用国家报销政策综述
Open Access J Contracept. 2024 Nov 14;15:107-118. doi: 10.2147/OAJC.S479397. eCollection 2024.
9
Impact of prior levonorgestrel intrauterine device use at the time of embryo transfer.胚胎移植时既往左炔诺孕酮宫内节育器使用情况的影响
Reprod Fertil. 2024 Dec 20;5(4). doi: 10.1530/RAF-24-0099. Print 2024 Oct 1.
10
Estrogens and breast cancer.雌激素与乳腺癌
Ann Oncol. 2025 Feb;36(2):134-148. doi: 10.1016/j.annonc.2024.10.824. Epub 2024 Nov 8.